|
#1
22.04.2024, 19:07
|
||||
|
||||
|
еше разок: анализы на полифорфизмы - мусор, ктобы вам их бы не назначал, можете обьездит и всю россию; но специалиста ребенку и не встретите; вы подменяете заботой о здоровье ребенка произведением кучи ненужных анализов из ее крови, про феринджект не "знать" нужно, а найти врача, который сделает; впрочем, понимаю что всё напрасно, станет она взрослой - скажите чтобы открыла новую тему от своего имени, ету закрываю.
(1) a significant delay (mean 36 months (3 years!), range 5-72 (6 years!!!) occurred between menarche and referral to specialty care, (2) HMB had moderate to severe impact on school and physical activities in 60% of patients, and (3) most patients (68%) required escalation of their initial therapy. The mean age was 14.5 ± 1.9 years. Fifteen (57.7%) reported dysmenorrhea, 13 (50%) complained of heavy menstrual bleeding (HMB), 10 (38.5%) reported irregular menses, and 7 (26.9%) sought contraception. Concurrent medical problems were reviewed, as this affected hormone choice. The cohort was stratified into 2 groups: patients whose menstrual cycles were well controlled on a single method (group A), and patients who tried multiple medications (group B). Progesterone-only pills were most commonly used in group A. Eleven (73%) patients in group B tried depot medroxyprogesterone acetate (DMPA), but ultimately a levonorgestrel intrauterine device (IUD) was the most popular final choice of treatment and was used by 4 (27%) patients. --- J Pediatr Adolesc Gynecol. 2020 Jun;33(3):291-295. Gynecologic Management of Pediatric and Adolescent Patients with Ehlers-Danlos Syndrome |
|
|
|
|
Комбинированный вид
